95%Confidence
0Views
FDASource
2026-04-16Date
Summary
Third Appco Pharma recall for Prazosin 5mg capsules confirms systemic nitrosamine contamination affecting all dosage strengths. This creates compounding regulatory and supply chain challenges for Biocon Pharma's entire Prazosin product line.
Actionable: Evaluate competitive landscape for Prazosin alternatives as supply disruptions may create market opportunities for competitors.
AI Confidence: 95%
Data Points
firmAppco Pharma LLC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productPrazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now